Page last updated: 2024-09-04

1-methyl-4-phenyl-2,3-dihydropyridinium and oxidopamine

1-methyl-4-phenyl-2,3-dihydropyridinium has been researched along with oxidopamine in 1 studies

Compound Research Comparison

Studies
(1-methyl-4-phenyl-2,3-dihydropyridinium)
Trials
(1-methyl-4-phenyl-2,3-dihydropyridinium)
Recent Studies (post-2010)
(1-methyl-4-phenyl-2,3-dihydropyridinium)
Studies
(oxidopamine)
Trials
(oxidopamine)
Recent Studies (post-2010) (oxidopamine)
46038,63062,407

Protein Interaction Comparison

ProteinTaxonomy1-methyl-4-phenyl-2,3-dihydropyridinium (IC50)oxidopamine (IC50)
Glyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)8
DNA repair protein RAD52 homologHomo sapiens (human)0.779

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albanese, A; Del Zompo, M; Morelli, M; Piccardi, MP; Ruiu, S1

Other Studies

1 other study(ies) available for 1-methyl-4-phenyl-2,3-dihydropyridinium and oxidopamine

ArticleYear
Localization of MPP+ binding sites in the brain of various mammalian species.
    Journal of neural transmission. Parkinson's disease and dementia section, 1992, Volume: 4, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Binding Sites; Brain Chemistry; Callithrix; Corpus Striatum; Female; Image Processing, Computer-Assisted; Male; Mice; Monoamine Oxidase; Oxidopamine; Pyridinium Compounds; Rats; Rats, Inbred Strains; Species Specificity

1992